Literature DB >> 2643422

Effects of chronic ethanol consumption in atherosclerosis-prone JCR:LA-corpulent rat.

J C Russell1, R M Amy, V Manickavel, P J Dolphin.   

Abstract

Rats of the atherosclerosis-prone JCR:LA-corpulent strain were subjected to long-term low (0.5% wt/vol) or high (4% wt/vol) consumption of ethanol from 1 to 12 months of age. The corpulent rats are hyperphagic, obese, and insulin-resistant; exhibit a marked very low density lipoprotein hyperlipidemia; and develop both vascular and myocardial lesions while eating a normal rat chow. The total lipid profile of the rat sera showed only limited changes with ethanol consumption. There were also no significant effects on high density lipoprotein lipids. Ethanol consumption was associated with elevated fasting glucose concentrations in both lean and corpulent rats and a strong decrease in fasting insulin levels and pancreatic B-cell volume density in the hyperinsulinemic corpulent rats. The relative frequency of myocardial nodules of chronic inflammatory cells was increased in the ethanol-consuming rats, both lean and corpulent. In contrast, old organized lesions (scars) were absent in the ethanol-consuming corpulent rats. Thus, ethanol consumption had no major effect on serum lipids or lipoproteins in the corpulent rat but was associated with a reduction in insulin resistance and islet cell hyperplasia, with an associated decreased incidence of myocardial lesions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2643422     DOI: 10.1161/01.atv.9.1.122

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  6 in total

1.  Insulin resistance and atherosclerosis.

Authors:  J C Russell
Journal:  CMAJ       Date:  1992-03-15       Impact factor: 8.262

2.  Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study)

Authors:  S Kiechl; J Willeit; W Poewe; G Egger; F Oberhollenzer; M Muggeo; E Bonora
Journal:  BMJ       Date:  1996-10-26

3.  Lewis phenotypes, insulin resistance, and risk of ischaemic heart disease.

Authors:  K Meeran; S R Bloom
Journal:  Br Heart J       Date:  1994-04

4.  Sustained decreases in weight and serum insulin, glucose, triacylglycerol and cholesterol in JCR:LA-corpulent rats treated with D-fenfluramine.

Authors:  D N Brindley; P Hales; A I al-Sieni; J C Russell
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

Review 5.  Cardiovascular disease in the JCR:LA-cp rat.

Authors:  J C Russell; S E Graham; M Richardson
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

6.  Animal models of coronary heart disease.

Authors:  Jiawei Liao; Wei Huang; George Liu
Journal:  J Biomed Res       Date:  2015-08-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.